Domantis L T D
USPTO Trademark & Patent Filings
Trademark applications and grants for Domantis L T D. Domantis L T D has 4 trademark applications. The latest application filed is for "DOMAIN ANTIBODY THERAPEUTICS"
| Patent Application | Date |
|---|---|
| ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L 20220073636 - 17/522008 NADLER; Steven G. ; et al. | 2022-03-10 |
| COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE 20210047414 - 17/086565 McKinnon; Murray ; et al. | 2021-02-18 |
| ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L 20190100595 - 16/218077 NADLER; Steven G. ; et al. | 2019-04-04 |
| POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS 20190040148 - 16/047197 JESPERS; Laurent ; et al. | 2019-02-07 |
| COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE 20180142023 - 15/870121 McKinnon; Murray ; et al. | 2018-05-24 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"DOMAIN ANTIBODY THERAPEUTICS" 78860689 |
DOMAIN ANTIBODY THERAPEUTICS 2006-04-13 |
"ALBUTHERAPEUTICS" 3324843 79027066 |
ALBUTHERAPEUTICS 2006-04-10 |
"ALBUDAB" 3318431 79018967 |
ALBUDAB 2005-07-25 |
"DOMANTIS" 2805779 78110455 |
DOMANTIS 2002-02-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 